Shanghai ZJ Bio-Tech Co. Ltd. A (SHG:688317) — Market Cap & Net Worth
Market Cap & Net Worth: Shanghai ZJ Bio-Tech Co. Ltd. A (688317)
Shanghai ZJ Bio-Tech Co. Ltd. A (SHG:688317) has a market capitalization of $460.30 Million (CN¥3.15 Billion) as of June 22, 2026. Listed on the SHG stock exchange, this China-based company holds position #12849 globally and #3820 in its home market, demonstrating a -4.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai ZJ Bio-Tech Co. Ltd. A's stock price CN¥16.37 by its total outstanding shares 192157999 (192.16 Million). Review Shanghai ZJ Bio-Tech Co. Ltd. A debt and liabilities to assess the company's total debt and financial obligations.
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap History: 2021 to 2026
Shanghai ZJ Bio-Tech Co. Ltd. A's market capitalization history from 2021 to 2026. Data shows change from $1.33 Billion to $460.30 Million (-22.94% CAGR).
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.54x
Shanghai ZJ Bio-Tech Co. Ltd. A's market cap is 4.54 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.33 Billion | $2.02 Billion | $758.52 Million | 0.66x | 1.76x |
| 2022 | $890.34 Million | $2.33 Billion | $760.27 Million | 0.38x | 1.17x |
| 2023 | $586.07 Million | $274.33 Million | -$136.86 Million | 2.14x | N/A |
| 2024 | $456.93 Million | $178.65 Million | -$127.46 Million | 2.56x | N/A |
| 2025 | $567.16 Million | $124.91 Million | -$34.30 Million | 4.54x | N/A |
Competitor Companies of 688317 by Market Capitalization
Companies near Shanghai ZJ Bio-Tech Co. Ltd. A in the global market cap rankings as of June 22, 2026.
Key companies related to Shanghai ZJ Bio-Tech Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
Shanghai ZJ Bio-Tech Co. Ltd. A Historical Marketcap From 2021 to 2026
Between 2021 and today, Shanghai ZJ Bio-Tech Co. Ltd. A's market cap moved from $1.33 Billion to $ 460.30 Million, with a yearly change of -22.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥460.30 Million | -18.84% |
| 2025 | CN¥567.16 Million | +24.12% |
| 2024 | CN¥456.93 Million | -22.03% |
| 2023 | CN¥586.07 Million | -34.18% |
| 2022 | CN¥890.34 Million | -33.19% |
| 2021 | CN¥1.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of Shanghai ZJ Bio-Tech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $460.30 Million USD |
| MoneyControl | $460.30 Million USD |
| MarketWatch | $460.30 Million USD |
| marketcap.company | $460.30 Million USD |
| Reuters | $460.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.